Molecular Biology and Bioinformatics Research Group, Department of Bioinformatics and Biosciences, Capital University of Science and Technology, Islamabad, PakistanE-mail: haroon.khan@cust.edu.pk
Abstract
Pancreatic cancer is a leading cause of fatality worldwide. Several population studies have been conducted on genetic diagnosis of pancreatic cancer but the results from epidemiologic studies are very limited. CYP17A gene has a role in disease formation but its influence on pancreatic cancer is unclear. A polymorphism in the 5’UTR promoter region of CYP17A1-34T/C (A1/A2) has been associated with multiple cancers. The aim of the current study was to assess associations of this polymorphism and socio-demographic risk factors with pancreatic cancer. A total of 255 and 320 controls were enrolled in the study, and were genetically analyzed through PCR-RFLP. Statistical analysis was conducted with observed genotype frequencies and odds ratios (ORs) and 95% CIs were estimated using unconditional logistic regression. The impact of socio-demographic factors was accessed through Kaplen-Meir analysis. According to our results, the A2/A2 genotype was significantly associated with pancreatic cancer (OR=2.1, 95%CI = 1.3–3.5). Gender female (OR=2.6, 95%CI=1.8–3.7), age group 80s/80+ years (OR=2.2, 95% CI=1.2-4), smoking both former (OR=4.6, 95% CIs=2.5-8.8) and current (OR=3.6, 95% CI=2-6.7), and family history (OR=7.1; 95%CI = 4.6-11.4) were also found associated with increased risk. Current study suggests that along with established risk factors for pancreatic cancer CYP17A1-34T/C may play a role. However, on the basis of small sample size the argument cannot be fully endorsed and larger scale studies are recommended.
Hussain, S., Bano, R., Tahir Khan, M., Haroon Khan, M. (2016). Association of the CYP17-34T/C Polymorphism with Pancreatic Cancer Risk. Asian Pacific Journal of Cancer Prevention, 17(S3), 71-75.
MLA
Shahid Hussain; Raisa Bano; Muhammad Tahir Khan; Mohammad Haroon Khan. "Association of the CYP17-34T/C Polymorphism with Pancreatic Cancer Risk". Asian Pacific Journal of Cancer Prevention, 17, S3, 2016, 71-75.
HARVARD
Hussain, S., Bano, R., Tahir Khan, M., Haroon Khan, M. (2016). 'Association of the CYP17-34T/C Polymorphism with Pancreatic Cancer Risk', Asian Pacific Journal of Cancer Prevention, 17(S3), pp. 71-75.
VANCOUVER
Hussain, S., Bano, R., Tahir Khan, M., Haroon Khan, M. Association of the CYP17-34T/C Polymorphism with Pancreatic Cancer Risk. Asian Pacific Journal of Cancer Prevention, 2016; 17(S3): 71-75.